The systematic identification and comprehensive characterization of FOXA1 transcriptional targets in NPC is essential to delineate its functional contributions to tumor progression and therapeutic resistance, while uncovering the molecular mechanisms that orchestrate these pathological processes. Here, FOXA1 is linked to neoplasm.